journal article·2018-01-01Open access

Controlled and localized delivery of c-myc AS-ODN to cells by 3-aminopropyl-trimethoxylsilane modified SBA-15 mesoporous silica

Juan Zhang, Minmin Chen, Xiqiu Zhao, Min Zhang, Jinxiang Mao, Xichuan Cao, Zhuoqi Zhang

AIP Advances· Volume 8· Issue 1

Abstract

SBA-15 mesoporous silicate was synthesized and functionalized with 3-aminopropyl organic groups through a post-synthesis method. The materials were characterized consecutively by powder X-ray diffraction (XRD), N2 adsorption/desorption analysis and solid-state magic-angle spinning 29Si nuclear magnetic resonance (MAS NMR). Human c-myc anti-sense oligodeoxyneucleotide (AS-ODN) was selected as a model molecule to be loaded onto the surface of bare and functionalized SBA-15 via different loading conditions. It has been found that the amount of AS-ODN incorporated into the porous matrix is strongly dependent on the surface properties, pH of the loading solvent and AS-ODN concentration. The release behaviour of AS-ODN from modified SBA-15 materials was also investigated and depended on conditions chosen. Cellular uptake of the eluted AS-ODN into Hela cells was observed by fluorescent microscopy. The materials showed excellent cytocompatibility. The AS-ODN keeps full transfection and expression activities indicating its structural integrity. The functionalized SBA-15 is an excellent prospect as a biomedical material candidate for the future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Mesoporous Materials and Catalysis · Biopolymer Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

China University of Mining and Technology 1 , Xuzhou 221116, China

Training Base of PLA Army Engineering University 3 , Xuzhou 221004, China

Department of Cardiology, Affiliated Hospital of Xuzhou Medical University 2 , Xuzhou 221002, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province

References (56)

Show source-provided references
1. The basic science of gene therapy10.1126/science.8493530 ↗
2. Gene therapy research in Asia10.1038/gt.2017.62 ↗
3. Gene therapy for Duchenne muscular dystrophy: Balancing good science, marginal efficacy, high emotions and excessive cost10.1177/1756285617717155 ↗
4. Adeno-associated virus as a gene delivery system10.1016/s0169-409x(97)00024-0 ↗
5. Retroviral vectors: From laboratory tools to molecular medicines10.1007/bf02789062 ↗
6. The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid mediated DNA delivery
7. Lipid-modified G4-decoy oligonucleotide anchored to nanoparticles: Delivery and bioactivity in pancreatic cancer cells10.1038/srep38468 ↗
8. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells10.1016/j.actbio.2017.06.032 ↗
9. Major limitations in the use of cationic liposomes for DNA delivery10.1016/s0378-5173(97)00423-7 ↗
10. Biodegradable nanoparticles as a gene expression vector
11. Peptide- and polymer-based gene delivery vehicles
12. Controlled delivery of anti-sense oligodeoxynucleotide from multilayered biocompatible phosphorylcholine polymer films10.1016/j.jconrel.2008.05.011 ↗
13. Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films10.1021/bm050840b ↗
14. Small-molecule release from poly(D,L-lactide)/poly (D,L-lactide-co-glycolide) composite microparticles10.1002/jps.20408 ↗
15. Modeling small-molecule release from PLG microspheres: Effects of polymer degradation and nonuniform drug distribution10.1016/j.jconrel.2004.11.012 ↗
16. Design and development of polymers for gene delivery10.1038/nrd1775 ↗
17. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate10.1021/la011736s ↗
18. Inorganic nanoparticles as carriers for efficient cellular delivery10.1016/j.ces.2005.06.019 ↗
19. Nanoparticles for cancer therapy and diagnosis10.1163/156855206775123494 ↗
20. Bio-functional inorganic materials: An attractive branch of gene-based nano-medicine delivery for 21st century10.2174/156652305774964613 ↗
21. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures10.1021/ja974025i ↗
22. Synthesis of mesoporous NH2-SBA-15 by a simple and efficient strategy10.1134/s0036024415120183 ↗
23. Pore size control of mesoporous molecular sieves using different organic auxiliary chemicals10.1016/j.micromeso.2003.12.010 ↗
24. The removal of template from SBA-15 samples synthesized from different silica sources10.1007/s10973-015-4568-2 ↗
25. Progress in pore-size control of mesoporous MCM-41 molecular sieve using surfactant having different alkyl chain lengths and various organic auxiliary chemicals10.1023/b:cats.0000015110.85694.d9 ↗
26. Critical assessment of the base catalysis properties of amino-functionalized mesoporous polymer-SBA-15 nanocomposites10.1016/j.apcata.2014.11.032 ↗
27. Immobilisation behaviour of biomolecules in mesoporous silica materials10.1016/j.catcom.2005.05.007 ↗
28. Experimental separation steps influence the protein content of corona around mesoporous silica nanoparticles10.1039/c7nr01654a ↗
29. pH-dependent selective protein adsorption into mesoporous silica10.1021/acs.jpcc.5b09606 ↗
30. High-temperature synthesis of ordered hexagonal mesoporous silica materials (SBA-15) with adjustable large mesopores for selective adsorption of biomolecules10.1002/ejic.201402511 ↗
31. Ordered mesoporous materials for bioadsorption and biocatalysis10.1021/cm0485658 ↗
32. Novelty of Penicillium camembertii lipase supported on glutaraldehyde activated-SBA-15 mesoporous silica for mono-esterification of bioglycerol in non-aqueous media10.1515/ijcre-2014-0058 ↗
33. Integrated, cascading enzyme-/chemocatalytic cellulose conversion using catalysts based on mesoporous silica nanoparticles10.1002/cssc.201402605 ↗
34. Adsorption study of heme proteins on SBA-15 mesoporous silica with pore-filling models10.1016/j.tsf.2005.07.046 ↗
35. Effective controlled release of captopril by silylation of mesoporous MCM-4110.1002/cphc.200500294 ↗
36. Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma10.1039/c7tb01217a ↗
37. Mesoporous silica nanoparticles with large pores for the encapsulation and release of proteins10.1021/acsami.6b11324 ↗
38. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
39. Mesoporous silica nanoparticles deliver DNA and chemicals into plants10.1038/nnano.2007.108 ↗
40. Mesoporous silica nanoparticles as drug delivery vehicles in cancer10.3390/nano7070189 ↗
41. The serum-resistant transfection evaluation and long-term stability of gene delivery dry powder based on mesoporous silica nanoparticles and polyethyleneimine by freezing-drying10.1208/s12249-016-0617-9 ↗
42. Functionalization of SBA-15 with APTES and characterization of functionalized materials10.1021/jp035877+ ↗
43. Synthesis and characterization of bifunctionalized ordered mesoporous materials10.1002/adfm.200305001 ↗
44. Functionalized SBA-15 materials as carriers for controlled drug delivery: Influence of surface properties on matrix-drug interactions10.1021/la051167e ↗
45. Polymer-based gene delivery with low cytotoxicity by a unique balance of side chain termini10.1073/pnas.98.3.1200 ↗
46. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells10.1161/01.cir.88.3.1190 ↗
47. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides10.1172/jci117036 ↗
48. Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model10.1016/s0735-1097(02)01830-2 ↗
49. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholinecoated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model10.1002/ccd.20007 ↗
50. C-myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy10.1159/000085379 ↗
51. Current status of catheter- and stent-based gene therapy10.1016/j.cardiores.2004.07.003 ↗
52. Plasmid DNA encapsulation and release from solvent diffusion nanospheres10.1016/s0168-3659(00)00353-9 ↗
53. Preparation and characterization of cationic PLGA nanospheres as DNA carriers10.1016/j.biomaterials.2003.08.069 ↗
54. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty10.1161/01.res.80.4.520 ↗
55. Simultaneous imaging of endogenous survivin mRNA and on-demand drug release in live cells by using a mesoporous silica nanoquencher10.1002/smll.201700569 ↗
56. Immobilization of enzymes in mesoporous materials: Controlling the entrance to nanospace10.1016/j.micromeso.2004.05.004 ↗